Why did PAINS hit a nerve?

“CDD spotlight” recently interviewed prof. Jonathan Baell the author of the notorious PAINS paper.

PAINS or Pan Assay Interference Compounds, are a class of compounds that commonly show up in high throughput screens (HTS) for small molecule inhibitors (you can read more about them here , here  and here).

When asked why in his opinion this paper made such an impact, Baell gave an interesting answer: basically it really hit a nerve, and the timing was just right. According to Baell, their group lead some of the first academic HTS efforts, and stumbled upon these PAINS molecules again and again. By the time the paper was published, there were probably dozens of academic labs performing screens and it really resonated with them. Another possible reason for the wide acceptance of this work might have been ex-pharma people, turned academics, who knew these molecules from their past but could not talk about them. Baell mentions for instance that for Chris Lipinski “it was a breath of fresh air…”.

From a practical stand-point you can use this server from the Oprea group to filter your molecules and avoid future PAINS.



Written by Nir London in: Interviews | Tags: , , ,

One Sided De-Novo Computational Design of a Protein-Protein Interaction

In a recent Science paper, Sarel Fleishman et al. report the de-novo computational design of a protein interface to specifically target and tightly bind a surface patch of the flu hemaglutinin protein. We interview Sarel to get the insights from behind the scenes and the outlook for this exciting approach.


Powered by WordPress | Aeros Theme | TheBuckmaker.com WordPress Themes
© 2009 Rosetta Design Group LLC